Long-term Follow-up of Gene Therapy for Radiation-Induced Xerostomia
Trial details
- Registry ID
- NCT06544798
- Drugs studied
- AAV2-hAQP1
TrialRedline tracks 2 clinical trials sponsored by MeiraGTx, LLC: 2 Phase 2.
Company identity has not yet been verified
| Trial | Drugs studied | Status | Primary completion |
|---|---|---|---|
| Long-term Follow-up of Gene Therapy for Radiation-Induced XerostomiaNCT06544798 | AAV2-hAQP1 | Enrolling by invitation | 2032-02Estimated |
| A Study of AAV2-hAQP1 Gene Therapy in Participants With Radiation-Induced Late XerostomiaNCT05926765 | AAV2-hAQP1 Concentration 1, AAV2-hAQP1 Concentration 2, AAV2-hAQP1 Concentration 3, AAV2-hAQP1 Concentration 4 | Active not recruiting | 2027-06Estimated |
Names as written in the registry records.
NCT05926765 · MeiraGTx, LLC
Before: Estimated. After: Actual.
Before: 276 participants (planned). After: 290 participants (actual).
Before: Dec 2026. After: Jun 2027.
Before: Recruiting. After: Active not recruiting.